Table 2.
Clinicopathological characteristics of breast cancer patients.
| n (%) | |
|---|---|
| Tumor size (mm) | 8.2 ± 5.24 |
| Histology | |
| IDC | 40 (81.6) |
| ILC | 2 (4.1) |
| Others | 7 (14.3) |
| ER status | |
| + | 30 (61.2) |
| - | 19 (38.8) |
| PR status | |
| + | 28 (57.1) |
| - | 21 (42.9) |
| HER2 status | |
| + | 35 (71.4) |
| - | 14 (28.6) |
Abbreviations: ER: estrogen receptor; IDC: invasive ductal carcinoma; HER2: human epidermal growth factor receptor 2; ILC: invasive lobular carcinoma; PR: progesterone receptor.